In addition to its association with tumour aggressiveness, high levels of CITED2 mRNA were also significantly associated with clinical benefit of tamoxifen treatment in advanced breast cancer independently of the traditional predictive markers including adjuvant chemotherapy. This evidence concerns the gene CITED2 and breast cancer.